Hutch News
Results per Page:
Community virus surveillance can double the data of vaccine trials
From Mr. Craig Magaret, Vaccine and Infectious Disease Division
Fred Hutch at CROI: COVID-19 vaccine efficacy trials, T-cell immunity following vaccination, immune responses to SARS-CoV-2, and late-breaking science on HPV, HIV and long-term antiretroviral therapy
Conference on Retroviruses and Opportunistic Infections to be held virtually March 6 – 10, 2021
New study looks at how persistent organic pollutants affect vaccines
New Fred Hutch study looks at whether persistent organic pollutants can undercut vaccines
HIV vaccine: Could a few special cells help protect millions of people?
New analysis finds rare immune cells linked to HIV vaccine’s effectiveness
Halloran named AAAS Fellow
VIDI disease modeler honored for her infectious-disease expertise